Generic Biosimilars 2018 invites all the participants from all over the world to attend “14th International Conference on Generic Drugs and Biosimilars’’ (Generic Biosimilars 2018) slated on November 15-16, 2018 Berlin, Germany which covers on all aspects of the pharmaceutical sciences, manufacturing, quality with strong emphasis on originality and scientific quality

ConferenceSeries organizes 1000+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 1000+ Open access journals which contain over 70000 eminent personalities, reputed scientists as editorial board members, 1200 Symposium & Workshops and 5 million followers. ConferenceSeries Ltd invites all the participants across the globe to attend the "14th International Conference on Generic Drugs and Biosimilars

Generic Biosimilars 2018 conveys recent developments in Generic drug marketing and production of generic drugs and contract manufacturing. A complete knowledge of a scientific discipline that described the effects of generic drug marketing and generic Pharma now explores the Scope of generic drug marketing in industry. Generic Biosimilars 2018 provides detailed market, technology, and industry analyses to help readers quantify and qualify the market for prescription generic drugs. Important trends are identified and sales forecasts by product categories and major country markets these are based on industry sources and considered assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the generic drug market. The wider economic environment is also taken into account.